Results 121 to 130 of about 1,296,096 (233)

In vitro and in vivo pharmacology of nine novel synthetic cannabinoid receptor agonists. [PDF]

open access: yesPharmacol Biochem Behav, 2022
Marusich JA   +4 more
europepmc   +1 more source

Hepatitis C Micro‐Elimination in a Deprived Coastal Town: Lessons From Blackpool

open access: yesPublic Health Challenges, Volume 5, Issue 3, September 2026.
By making hepatitis C virus (HCV) testing a routine part of care, Blackpool's drug and alcohol services dramatically improved HCV diagnosis and treatment and achieved HCV micro‐elimination. Continued commitment to this new way of working will be essential to sustain these gains.
Sarah E. Blagden   +2 more
wiley   +1 more source

Predicting affinity and potency of new psychoactive substances at cannabinoid 1 receptor with explainable artificial intelligence

open access: yesFrontiers in Pharmacology
Introduction Binding affinity and functional potency are two distinct but pharmacologically related properties in ligand-receptor interactions. The molecular features influencing these two endpoints may differ, reflecting distinct physicochemical and ...
Verena Schöning   +9 more
doaj   +1 more source

#NoIDVape: A content analysis of illicit vape messaging in young people's information sources

open access: yesAddiction, Volume 121, Issue 9, Page 2396-2413, September 2026.
Abstract Background and aims In recent years, the increased prevalence of youth vaping in the United Kingdom (UK) may have coincided with a proliferation in the use of ‘illicit’ (unregulated) vapes. Media or educational content about illicit vaping aimed at young people is scarce and poorly understood.
Eleanor Bray   +5 more
wiley   +1 more source

Characteristics of deaths due to drug‐related causes among individuals recently released from prison in the United Kingdom, 1997–2025

open access: yesAddiction, Volume 121, Issue 9, Page 2545-2551, September 2026.
Abstract Background and aims There has been an extensive literature describing the elevated risk of drug‐related death following an individual's release from prison; however, few previous studies have reported nationally representative samples or provided granular detail as to which individual drugs were deemed implicated in death.
Emmert Roberts   +2 more
wiley   +1 more source

Bonzai Intoxication in Children: Our Experience with 17 Cases

open access: yesThe Turkish Journal of Pediatrics, 2015
Synthetic cannabinoid receptor agonists are becoming increasingly popular in adolescent age group as an abused substance. Therefore, pediatric emergency physicians should be prepared for Bonzai utilizations which are being more common day by day ...
Sevgi Yaşar Durmuş   +4 more
doaj  

Cannabinoid Receptor Modulation in Focal Ischemic Stroke: A Systematic Review and Meta-Analysis of Infarct Volume and Behavioral Deficits in Animal Models

open access: yesMedical Principles and Practice
Objective: This systematic review and meta-analysis aimed to evaluate the impact of cannabinoid (CB) receptor modulation on infarct volume and behavioral deficits in animal models of focal ischemic stroke, with a primary focus on infarct ...
Hussain Al Dera   +7 more
doaj   +1 more source

Photochemical Fingerprinting Is a Sensitive Probe for the Detection of Synthetic Cannabinoid Receptor Agonists; toward Robust Point-of-Care Detection. [PDF]

open access: yesAnal Chem, 2023
Andrews RC   +16 more
europepmc   +1 more source

Extended‐release buprenorphine in adults with opioid use disorder involving poppy seed tea: An 18‐month retrospective case series

open access: yesThe American Journal on Addictions, Volume 35, Issue 5, Page 638-642, September 2026.
Abstract Background and Objectives Poppy seed tea (PST) contains unpredictable opioid concentrations, destabilising tolerance and increasing overdose risk. Extended‐release buprenorphine (BUP‐XR) provides sustained coverage without daily dosing. Methods Eighteen‐month follow‐up of adults (N = 3) with opioid use disorder (OUD) involving PST in Australia.
John McMaster   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy